Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H-P Tony

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Zeitschrift Fur Rheumatologie|October 8, 2011
[Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis]J R Kalden, H Burkhardt, B Buss, et al.
Lupus|September 24, 2013
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)M Witt, M Grunke, F Proft, et al.
Zeitschrift Fur Rheumatologie|June 8, 2017
[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)]F Proft, H Schulze-Koops, M Grunke, et al.
Zeitschrift Fur Rheumatologie|August 30, 2012
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]K Krüger, J Wollenhaupt, K Albrecht, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Zeitschrift Fur Rheumatologie|July 4, 2018
[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]C Fiehn, J Holle, C Iking-Konert, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Zeitschrift Fur Rheumatologie|October 8, 2011
[Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis]J R Kalden, H Burkhardt, B Buss, et al.
Lupus|September 24, 2013
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)M Witt, M Grunke, F Proft, et al.
Zeitschrift Fur Rheumatologie|June 8, 2017
[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)]F Proft, H Schulze-Koops, M Grunke, et al.
Zeitschrift Fur Rheumatologie|August 30, 2012
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]K Krüger, J Wollenhaupt, K Albrecht, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Zeitschrift Fur Rheumatologie|July 4, 2018
[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]C Fiehn, J Holle, C Iking-Konert, et al.
Pageof 9